Center Star Asset Management, LLC Gilead Sciences, Inc. Transaction History

Center Star Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $1.52 Million - $1.74 Million	-25,367 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $1.55 Million - $1.77 Million	-27,432 Reduced 51.96%	25,367 $1.44 Million
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $2.71 Million - $3.41 Million	43,628 Added 475.72%	52,799 $3.28 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $563,166 - $653,940	7,785 Added 561.69%	9,171 $684,000
Q1 2020 Apr 13, 2020	BUY	$62.63 - $80.22 $86,805 - $111,184	1,386 New	1,386 $105,000
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $6,531 - $7,184	-106 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $6,626 - $7,314	106 New	106 $7,000
Q4 2018 Jan 16, 2019	SELL	$60.54 - $79.0 $65,625 - $85,636	-1,084 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$71.28 - $78.92 $58,877 - $65,187	826 Added 320.16%	1,084 $83,000
Q2 2018 Jul 09, 2018	SELL	$64.88 - $75.68 $3.68 Million - $4.3 Million	-56,788 Reduced 99.55%	258 $18,000
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $4.07 Million - $4.96 Million	55,875 Added 4771.56%	57,046 $4.27 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $83,316 - $97,801	1,171	1,171 $85,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.